Mirae Asset Global Investments
BVS icon

Mirae Asset Global Investments’s Bioventus BVS Stock Holding History

Mirae Asset Global Investments’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-13,452
Closed -$94K – 2537
2022
Q3 		$94K Buy
+13,452
New +$105K ﹤0.01% 2512

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Mirae Asset Global Investments's BVS Position: Q4 2022 in Review

Mirae Asset Global Investments sold out of Bioventus (BVS) in Q4 2022, closing a stake of 13,452 shares — an estimated $94K sold.

Mirae Asset Global Investments first reported a position in BVS in Q3 2022 and held it in 1 quarter. The position peaked at $94K in Q3 2022. 85 funds tracked by Wall St. Rank hold BVS as of Q4 2022.

  • Mirae Asset Global Investments reported no remaining Bioventus position as of Q4 2022 after selling out during the quarter.
  • Mirae Asset Global Investments sold 13,452 Bioventus shares in Q4 2022, an estimated $94K.
  • Mirae Asset Global Investments first reported a position in Bioventus in Q3 2022 and held it in 1 quarter.
  • Mirae Asset Global Investments's Bioventus position peaked at $94K in Q3 2022.
  • 85 funds tracked by Wall St. Rank held Bioventus as of Q4 2022.

Based on Mirae Asset Global Investments's 13F filing for Q4 2022, filed 9 Feb 2023.